Manorama Industries Limited
Industry Context
See moreHide details
Industry Context
Industry Context is not ready yet for this company.
We have not generated company-specific industry context for this company yet.
Business Snapshot
06 MarSee moreHide details
Business Snapshot
About
Producer of cocoa butter equivalents and specialty fats derived from forest-sourced tree-borne seeds.
The company transforms underutilized natural resources like Sal seeds and Shea nuts into sustainable specialty fats and butters for the global chocolate, confectionery, cosmetics, and bakery industries through an integrated 'forest to fortune' model.
Revenue Breakdown
By Segment
Chocolate and Confectionery
Supply of cocoa butter equivalents and specialty fats for chocolate and candy production.
Cosmetics
Production of exotic plant-based butters and ingredients for personal care and beauty products.
Show more (1)
Bakery and HoReCa
Specialty fats and ingredients tailored for the bakery, hotel, restaurant, and cafe industries.
By Product / Service
Cocoa Butter Equivalents (CBE)
Fats derived from tree-borne seeds that mimic the properties of cocoa butter.
Refined and Fractionated Butters
Customized specialty fats and butters for diverse food and personal care applications.
Show more (1)
De-Oiled Cake (Cattle Feed)
A by-product of the seed extraction process used for animal nutrition.
Quarterly Score
Score trend
12 quartersLatest 12 quarters, oldest to newest. Click a point to inspect that quarter.
Quarter
Q3 FY2026
LatestStrongly BullishQuarter summary
- The company sustained robust growth momentum, attributing it to an enhanced value-added product mix and optimized utilization of recently upgraded facilities.
- A significant strategic capital expenditure plan of INR 460 crores was announced for both forward and backward integration, targeting long-term capacity and market leadership.
Rationale
- Achieved exceptional revenue growth of 73.3% YoY in Q3 FY26 (INR 363 crores) and 81.3% YoY in 9M FY26 (INR 975 crores), primarily driven by ~65% volume growth and an enhanced mix of value-added products.
- Upwardly revised FY26 revenue guidance by ~13% (from INR 1,150 crores to INR 1,300 crores), demonstrating strong confidence in sustained performance and market demand.
Latest quarter context.
Future Growth Prospects
Summary
Updated: 05 Mar 2026- • Expanding fractionation capacity to 52,000 MTPA by FY26 through debottlenecking, enhancing throughput by 30%.
- • Committing INR 460 Crores capex over the next 2-3 years for new facilities: 75k MTPA for CBE alternatives, 75k MTPA for solvent fractionation (ESOS), 90k MTPA for refinery, and 90k MTPA processing in Burkina Faso.
- • Targeting a significant shift towards value-added product sales, aiming for 85%-90% contribution to total sales 'going forward'.
Top 3 Growth Catalysts
New Capacity Expansion & Debottlenecking
Timeline
- scale expansionFY24 · ppt
Fractionation capacity increased from 15,000 TPA to 40,000 TPA.
25,000 TPA added
- ramp upQ3 FY26 · concall
Debottlenecking existing capacity to 52,000 MTPA by end of FY26.
Existing capacity increasing by 12,000 MTPA
Show full timeline (5)
- commissioningFY28 · concall
All new production capacity (~460 Cr capex projects) expected to be commenced.
Full new capex expected online
- commissioningJuly 2024 · ppt
New 25,000 MTPA fractionation facility commercialized, taking total to 40,000 MTPA.
New facility commercialized
- capex startNext 2-3 years · concall
INR 460 Cr capex for 75k MTPA CBA, 75k MTPA solvent fractionation, 90k MTPA refinery, 90k MTPA Burkina Faso processing.
Significant new facilities planned
Product Diversification & Value-Added Mix Shift (CBA/ESOS)
Timeline
- unknownQ3 FY26 · concall
New fractionation capacity will be used for ESOS and HPMF, blended with existing stearin to make value-enhanced products.
Shift to value-enhanced ESOS products
- first mention2024-25 · annual_report
Launched new value-added products.
New products introduced
Show full timeline (4)
- unknownNext 2-3 years · concall
Setting up 75k MTPA CBA manufacturing facility and 75k MTPA new Solvent Fractionation facility for ESOS.
New dedicated facilities for value-added products
- quantified guidanceGoing forward · concall
Aim to increase value-added product sales to 85%-90%.
Higher proportion of value-added sales expected
Global Geographical Expansion & Backward Integration (Africa & Latin America)
Timeline
- ramp upQ3 FY26 · concall
First commercial production batch at Dekel (Brazil partnership) accomplished, trial samples delivered.
Initial production in Brazil
- commissioningNovember 2025 · ppt
Production expected to commence in Brazil partnership.
Brazil manufacturing commencement
Show full timeline (4)
- first mention2024-25 · annual_report
Established 8 new subsidiaries globally across critical geographies.
New global subsidiaries formed
- capex startNext 2-3 years · concall
Backward integration to processing factory in Burkina Faso (90k MTPA).
Processing facility planned in Africa
See more about future growth
Open detailed variant perception and scenario analysis.
OpenHide
See more about future growth
Open detailed variant perception and scenario analysis.
Variant perception
Non-consensus viewThe market acknowledges Manorama’s robust growth and capacity expansion plans but may be largely factoring in the guided FY26 revenue and current margin stability, without fully discounting the acceleration from upcoming large-scale project
- Faster than guided ramp-up of 460 Cr capex projects driving earlier revenue and margin realization.
Show more (2)Hide extras
- New value-added products (CBA/ESOS) achieve higher penetration and pricing power than currently de-risked.
- Operational synergies from global expansions and backward integration result in significant cost reductions and improved working capital beyond current targets.
- Execution delays or cost overruns in the INR 460 Cr capex projects, pushing out benefits beyond the 2-year horizon.
Show more (2)Hide extras
- Intensified competition or lower demand for specialty fats/butters could temper new product revenue growth.
- Inability to fully integrate new global subsidiaries or achieve projected efficiencies from backward integration.
Quick takeaway
Capacity expansion to 52,000 MTPA by FY26 end
Risk watch: Delays in new capacity commissioning beyond FY26
Show details (2 drivers, 2 risks)Hide details
Drivers
- Capacity expansion to 52,000 MTPA by FY26 end
- Continued shift to 75-85% value-added product sales
Risks
- Delays in new capacity commissioning beyond FY26
- Increased competition in new geographies
Quick takeaway
Accelerated ramp-up and full utilization of new facilities (CBA, Solvent Fractionation, Refinery)
Risk watch: Potential for unexpected operational issues during new plant stabilization
Show details (2 drivers, 2 risks)Hide details
Drivers
- Accelerated ramp-up and full utilization of new facilities (CBA, Solvent Fractionation, Refinery)
- Higher-than-expected demand for ESOS and other value-enhanced products
Risks
- Potential for unexpected operational issues during new plant stabilization
- Market volatility impacting new product adoption
Quick takeaway
Increased cost efficiencies from backward integration in Africa
Risk watch: Execution risks in commissioning new plants
Show details (2 drivers, 2 risks)Hide details
Drivers
- Increased cost efficiencies from backward integration in Africa
- Faster customer acquisition in Latin America
Risks
- Execution risks in commissioning new plants
- Higher raw material price volatility affecting new product margins
Guidance History
Not readyGuidance History is not ready yet for this company.
We have not tracked meaningful management guidance for this company yet.
Community
Share your view anonymously. Comments are public and sorted newest first.
Anonymous post · 1500 characters left